Novartis inks injectable tech deal with Unilife; India tries to counter negative quality perceptions;

> Novartis ($NVS) has joined Sanofi ($SNY) and MedImmune on the list of companies sourcing injectable technology from Unilife. Article

> India is trying to counter negative publicity by showcasing its best production plants to officials from other countries. Feature

> Liqvor is set to become the first Armenian company to receive European GMP certification. News

> A European trade group has called proposed revisions to GMP guidelines "very unrealistic." Piece

> ReNeuron thinks its frozen CTX cell line gives it a major competitive advantage. Item

> An accident at AMPAC Fine Chemicals has hospitalized 7 people. Brief

> TxCell has received manufacturing accreditation status at its French cell therapy plant. Release